细胞膜钙ATP酶在心肌缺血再灌注和腺苷诱导预适应中的作用

1、细胞膜钙ATP酶在心肌缺血/再灌注和腺苷诱导预适应中的作用    【摘要】  目的：探讨在心肌缺血/再灌注和腺苷诱导预适应过程中细胞膜钙泵（PMCA）的可能作用。方法：将培养的乳鼠心肌细胞分为3组：缺血/再灌注组、腺苷预处理组和对照组。各组乳酸脱氢酶（LDH）漏出量以生化法检测（n5）；半定量RT?PCR检测各组PMCA基因转录水平（n3）；PMCA活性以定磷比色法测定（n5）。结果：（1）缺血/再灌注组LDH漏出量明显增高(P<0.001)，腺苷预处理组LDH漏出量显著降低(P<0.001)；（2）各组间PMCA mRNA转录水平

2、无显著性差异（P>0.05)；（3）各组间PMCA蛋白活性无显著性差异（P>0.05)。结论：在乳鼠心肌细胞缺血/再灌注过程中PMCA无代偿功能；PMCA不直接参与腺苷诱导预适应的心肌保护作用。 【关键词】  钙ATP酶 钙 再灌注损伤 药物预处理 大鼠 Sprague?Dawley     Abstract:Objective  To study the effectiveness of interstitial irradiation by 32P?chromic phosphate (32P?colloid) on

3、the latent metastasis during lung cancer resection. Methods  73 patients with lung cancer underwent resection of tumor and interstitial administration of 32 P?colloid, by the same time span, 58 patients with same diagnosis underwent operation served as control group. After operation the dynamic

4、 distribution of body surface 32P?colloid activity, incidence of complication, rates of supra?clavicle lymph node (SCL) metastasis in different pathologic patterns, and survival rates at 1?,3?,5? year were studied. Results  No operative death occurred in these two groups. The pathologic pattern

5、s, incidences of lymph node metastasis and the incidences of major complication after operation were no significant differences between these two groups (20.0031.696,P>0.05). The incidence of post?operative SCL metastasis in surgery plus 32P?colloid group was significantly lower than that in surg

6、ery group（24.5075.348,P<0.05 or P<0.01）.1?,3?,5? year survival rates of the former group were 82.2%,56.2% and 38.7%, those of the latter group were 77.6%,41.7%and 25.5%. In reviewing the 1?,3?,5?year survival rates in different pathologic pattern groups, there was no significant statistical di

7、fference between groups of the 1?year survival rates (20.659,P>0.05), but the differences between the two groups of the 3?,5?year survival rates were significantly (24.207,3.997,P0.05). Conclusion  Interstitial injection of 32P?colloid during resection of lung cancer is a safe and effective

8、procedure in controlling the latent lymphatic metastasis and local recurrence, and is surely to prolong the survival time of patients.    Key words：lung cancer; lymphatic metastasis; operative treatment; radiotherapy; 32P?colloid; phosphorus radioisotopes    CLC number

9、R734.2; R817.541    Document code A    Article ID 1671?6264(2008)04?0244?06    China is one of the countries in Asia where smoking rates are now high and where lung cancer is becoming more and more frequent as a consequence. In order to give patients with

10、 lung cancer a better therapy, many methods have been tried including improvement of surgical resection, a more thoroughly intrapulmonary lymph nodes dissection, and a better chemotherapy and radiotherapy1?2. Interstitial irradiation using 32P?chromic phosphate (32P?colloid) on the latent metastasis

11、 during lung cancer resection is a new method and has never been reported. From March 1997 to March 2001, we randomly choose 103 patients who underwent resection of tumor and gave them the interstitial injection of 32 P?colloid by the same time span. We choose 73 of these patients who had integrated

12、 data and 58 patients with same diagnosis underwent operation served as control group. Incidence of complication, rates of supra?clavicle lymph node (SCL) metastasis in different pathologic patterns, and survival rates at 1?,3?,5?year were studied, and the results are as follows.    1

13、  Materials and Methods    1.1  Subjects    In surgery plus 32P?colloid group there were 73 patients, including 48 males and 25 females, aged 32-83 years (53.5 years in average ). The pathologic patterns in these patients were squamous cell carcinoma 48 cases(

14、65.8%),   adenocarcinoma 15  cases (20.5%) and small cell carcinoma 10 cases (13.7%). There were 58 patients in the control group who had only undergone surgical therapy including 33 males and 25 females, aged 36-74 years(51.5 years in average ). Their pathologic patterns were squamou

15、s cell carcinoma 40 cases (69.0%), adenocarcinoma 13 cases (22.4 % )and small cell carcinoma 5 cases(8.6%).  The primary disease of all patients in the two groups were diagnosed after the examinations of chest X?ray, chest CT, fibre bronchoscope and sputum exfoliative cell examination before su

16、rgery. All routine examinations and Karnofsky score before surgery pointed out that all these patients were able to endure thoracotomy. Follow?up studies were performed in the third and the sixth month after discharged from hospital, then once every half year. On the first follow up visit, chest X?r

17、ay examination, chest CT or related serological examination were taken, thereafter inquired patients quality of life. The follow?up period was 12-60 months.    1.2  Operation methods    All patients of these two groups underwent thoracotomy either unilateral pneumo

18、nectomy or lobectomy with resection of visible lymph nodes. The lymph node of homolateral mediastimun were explored and carried out pathological examination and clinical staging. Among 73 cases of surgery plus 32P?colloid group there were unilateral pneumonectomy 15 cases (20.5%) and lobectomy 58 ca

19、ses (79.5%) while among 58 cases of the control group unilateral pneumonectomy 12 cases (20.7%) and lobectomy 46 cases (79.3%).     1.3  Method of 32P?colloid administration    32P?colloid was supplied by Gaotong Isotope Co. Ltd, Chengdu,China. It is a pale gr

20、een clarified solution, the diameter of colloid granule was 20-50 nm. The administrated activity for patients whose lung cancer have been incised was generally 296-370 MBq.  The primary solution should be diluted to 10 ml with normal saline, well mixed and aspirated into a sterile syringe for u

21、se. During operation, after resection of diseased lung and visible LN, infiltrative injection were carried out respectively to the fatty and connective tissues at the bed of resected tumor, neighbor to the pulmonary hilar, carina, upper mediastinum and the sites suspected to have metastasis. &#

22、160;  In the processing of the primary solution and injection, one should be careful to avoid any contaminations to the surroundings or utensils. Used syringes and the primary solution containers should be collected, sealed and disposed as the radioactive polluted material. Metal surgical appar

23、atus should be rinsed with a large quantity of running water first and then handled as usual.    1.4  Postoperative treatment    Surgery plus 32P?colloid group and the control group were managed routinely. The postoperative treatment was same in both groups. For ch

24、emotherapy etoposide 100 mg?m-2 continuous intravenous infusion on first 3 days；cisplatin 80 mg?m-2, intravenous on first day, 21 days as a session, treatment completed with 4 sessions, and immunotherapy thymosin 1.6 mg, injected subcutaneously in long term. To 10 patients in surgery plus 32P?colloi

25、d group after operation, we adopted radioactivity surface contamination surveyor with digital finger?shaped probe (Type ZC201) and put it on fixed sites of body surface, i.e., upper, middle and lower parts of lung fields on both sides, midaxillary lines, two inferior scapula angles, supra?sternal re

26、gions, xiphoid process, liver, spleen etc.daily to measure radioactive count for 10 s.  We also recorded radioactive counting rates in drained pleural effusion daily.    1.5  Statistical analysis    Software of SAS (6.12 edition) was used. The period from begi

27、nning of treatment to the death of patient was defined as the survival period. The survival rates at 1, 3, 5?years are calculated by life table method. We performed Chi square test for the comparison among postoperative complications, LN positive rates, and post?operative metastatic rates of SCL and

28、 survival rates in various pathologic patterns of the two groups. P0.05 indicated significant difference.    2  Results    2.1  Postoperative adverse reactions and complications    There was no operation death in either group. Routine blood exam

29、inations after surgery showed that the functions of both liver and kidney had restored to the level before operation. Patients of surgery plus 32P?colloid group had no adverse gastrointestinal reaction or hyperpyrexia. The main complications during the peri?operation were shown as Tab 1 below, and t

30、here were no significant difference between the two groups (P>0.05)    2.2  The pathologic patterns, staging of patients and positive lymph nodes    Staging of the patients of two groups (operation group & operation + 32P?colloid group ) were classified as s

31、tage I, stage (including A&B）and stage IIIA according to the “TNM classification of malignant tumors” UICC,1997. The results were presented as the number of positive LN vs the total ones which were excised during the operation, and there was no significant difference between the two groups (P>

32、;0.05, Tab 2).    Tab 1  Main complications during peri?operation    ComplicationOperation+32P?colloid    groupControl  groupARDS6.8%（573）8.6%（558）empyema4.1%（373）3.4%（258）pulmonary infection9.6%（773）10.3%（658）infection of incision wound5.5%（473

33、）6.9%（458）arrhythmia9.6%（773）8.6%（558）bronchopleural fistula00    Operation +32P?colloid group vs the control group by chi square test (2=0.0210.144,P>0.05)    2.3  The dynamic distribution of body surface radioactivity after interstitial administration of 32P?c

34、olloid    The detected radioactivity on thoracic surface was extenuated due to bandage dressing, therefore the detected activity at sternal fossa was higher than that at the sites of interstitial injection, the next was the interstitial injection site and ipsilateral mid axillary line

35、, generally the ipsilateral lung field activity was 2 or more times than that of the contralateral side. The activity in liver field was slightly lower than that of lung field, and that of spleen field was lower than liver field. The first day detected data of radioactivity on the surface of interst

36、itial injection sites was defined as the standard; the effective half degradation time was more than 15 days. The activity on the rest sites degraded rapidly beginning from the third day and subsequently it went down slowly and kept at low level. The radioactivity could be detected in pleural effusi

37、on two days after operation, and then lowered to the background level after further two days. Therefore the pleural effusion within 3 days after operation should be disposed into the radioactive disintegration pool as the routine procedure demanded.    2.4  Observation of curativ

38、e effects    Follow?up was based on periodical examination to detect whether SCL enlarged or not, and accompanied by type?B sonography of neck, chest X?ray examination, CT, MRI and others. SCL metastases detected after resection were mainly located on right side; the number of metasta

39、sis on the right side was 2 times to that of the left side. The SCL metastasis rates of various pathological patterns were shown in Tab 3. The survival rates of 1, 3 and 5 years after resection for surgery plus 32P?colloid group and the control group were shown in Tab 4. Tab 2  TNM stages and p

40、ositive rates of LN vs total LN    There was no significant difference of either TNM classification or  positive rate of LN of the between the two groups of all the three pathologic patterns （2=0.012,2.082,0.003,P0.05）Tab 3   Metastasis rates of SCL in lung cancer patie

41、nts with different pathological patternssss    3  Discussion    The lung cancer without metastasis deserves the best curative effect with surgical resection. Most surgeons prefer to take an intrapulmonary lymph nodes dissection whether the operation is radical or n

42、ot. And this demonstrates that the metastasis of the lymph nodes makes the difference between the success and failure after the surgical operation. Most recurrence and metastasis of the lung cancer happens within 2 years after operation, so these are the important factors relating to the survival ra

43、te. Previous researches have proved that this may relate to the occult micro metastasis foci in blood or lymphatic system 3. Other researchers reported that the ratio of latent metastasis after the breast carcinoma was about 33% 4, and there existed significant differences between whether the patien

44、t had the latent metastasis or not , and the differences was also significant relating to the 5?year survival rate. Latent metastasis refers to those metastases of petty lymph nodes which are missed in diagnosis during routine pathological examination so that it is also called latent metastases of l

45、ymph nodes, the peculiar histopathologic pictures with immuno?histochemical staining are its final diagnosis criterions5. The use of different preparations of 32P in treating solid tumors, such as pancreatic carcinoma, hepatic carcinoma et al, had got certain effectiveness6?7. It has been reported t

46、hat some researchers used the 32P?colloid（185?370 MBq）to cure the patients with malignant pericardial effusion and the effective rate was 94.5% without any side effects within 8 months8. Interstitial or intracavitary injection of the 32P?colloid had few side effects on the hemopoietic system, and wi

47、thout any side effects after operation. Animal experiment discovered 32P colloid injected into the implanted tumor mass of human pancreatic carcinoma cell Pc?3 loaded mice, executed on 14 d, metastatic Pc?3 was found in the inguinal lymph node（ILN）of control animal, while in treated animal the ILN p

48、resented apoptosis of metastatic tumor cells. In the treated group the development of lymphadenectasis is slower comparing with the control group, and the size of LN in also smaller9?10. This fact is the evidence illustrating the route of 32P colloid migration after interstitial injection in accorda

49、nce to that of metastasis along the lymphatic system. 32P colloid has favorable killing and inhibiting effect on tumor cells and the metastatic micro foci in LN, and mild toxic effect on the neighboring tissues.    Tab 4  Comparison of 1? ,3?,5? year survival rates%  &#

50、160; Pathologic patternsOperation+32P?colloid group1yr 3 yrs5yrs Control group1yr3yrs5yrsP*1yr3yrs5yrsSquamus cell carcinoma85.462.945.382.547.928.7P0.05P0.05P0.05Adenocarcinoma8053.430.576.930.720.5P0.05P0.01P0.05Small cell carcinoma703004000P0.01P0.01    *Comparison of 1?,3?,5? year

51、 survival rates between two groups (2：Squamus cell carcinoma: 0.312,4.553,5.91；Adenocarcinoma：0.284,10.573,2.632；Small cell carcinoma：18.182,35.294)    The present research adopted surgical incision, assisted by 32P?colloid interstitial injection to prevent cancer from relapse and met

52、astasis. The location of interstitial injection was in the exposed place of surgery field and it was also the drainage field of regional lymph node where cancer lied. Owing to the diffused interstitial administration after excision of tumor, the performing of ?bremsstrahlung imaging could not be obs

53、erved on the body surface. By detecting the post operative dynamic distribution of relative radioactivity from sub areas of body surface, it will substantially understand the distribution in vivo. The results demonstrated that the quantity of 32P?colloid retained in the contra lateral side is half o

54、f those on operation side, which indicated that although interstitial infiltration injection of 32P?colloid was mainly distributed in place of injection, part of it was phagocytized by macrophages and transported through lymphatic circulation into blood circulation. They could kill the spreading can

55、cer cells which were resulted from squeezing and bleeding during operation, and subsequently preventing the lung hilum mediastinum and anterior scalenus muscles or SCL metastases of the opposite side. It was reported in analyzing 233 cases of SCL metastasis, no matter the pathological entities 

56、 were  adenocarcinoma , squamous carcinoma or undifferentiated carcinoma, their  primary lesions were mostly in lung. Because drainage region of SCL was wide and there was no valvular structure in the efferent ducts of SCL, thoracic duct and right lymph duct, cancer cells   in ma

57、in lymphatic vessels might retrogradely move to SCL11. 32P?colloid injected interstitially might take the same path to eliminate cancer cells. The results of this research showed that post?operative SCL metastisis rates in surgery plus 32P?colloid group are markedly lower than those of the control g

58、roup, and that demonstrated the surgery matched with 32P?colloid had a remarkably curative effect for lymphatic duct metastasis and particularly more effective in treating  adenocarcinoma and small cell carcinoma which were liable to spread. In our research, most patients of the control group r

59、ecurred or had  metastasis in thorax within 2 years after operation and died mostly from distant metastasis to brain or bone and their survival rates at 1?,3?and 5? years were close to those reported in the literature. In their reports, the authors insisted that the chemotherapy and radiotherap

60、y might have a good short?term effect but a worse and worse long?term effect 12. And the reason may due to the injury of the body and the descent of the immunity caused by the chemotherapy and the radiotherapy. So the survival time is hard to prolong. In our study the 1?,3?,5? year survival rates of

61、 surgery32P colloid group is higher than those of control group with significant statistical difference(P<0.05), denoted that surgery plus 32P colloid can effectively kill the occult metastatic foci, and control the postoperative focal relapse and distant metastasis, resulted in prolonging the me

62、dium and long term surviving time.    The statistics showed that the surgery plus 32P?colloid can significantly improve the 3? year survival rate of the lung cancer. And the data had demonstrated the advantage of this therapy vs the control group. The 5? year survival rate of the 32P?colloid group